Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $72.6700 (3.58%) ($68.4400 - $72.6700) on Fri. Dec. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 30 | Latest Price | $72.6700(3.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -5.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWN(48%) IWM(47%) IWC(46%) IWO(45%) SDY(40%) | Factors Impacting LGND price | LGND will decline at least -2.105% in a week (0% probabilities). VXX(-21%) SHY(-15%) XBI(-9%) GLD(-8%) VCSH(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $57.04(-21.51%) | Resistance Level | $74.37 | 5 Day Moving Average | $71.69(1.37%) | 10 Day Moving Average | $73.51(-1.14%) | 20 Day Moving Average | $74.37(-2.29%) | To recent high | -25.3% | To recent low | 17.6% | Market Cap | $1.168b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |